Thierry Vander Borght

Nuclear medicine in oncology

Pr Thierry Vander BorghtProf. Thierry Vander Borght MD, PhD

CHU UCL Namur, Site Godinne, Department of Nuclear medicine

Member of Institute of Experimental and Clinical Research (IREC), UCLouvain

ORCID | ResearchGate | LinkedIn

Expertise and research interests

Radioimmunotherapy - Molecular Imaging - Cancer Imaging - Neuroimaging - SPECT - PET 

Research projects

  • Sentinel node imaging to individualize radiotherapy volumes in Head and Neck cancer. Research collaboration between Dr. Jean-François Daisne, Benoît Bihin, Dr. Marc Laloux, Prof. Thierry Vander Borght, Dr. Isabelle Mathieu and Prof. Georges Lawson, CHU UCL Namur.

Selected publications

Mahiat C, Bihin B, Duplaquet F, Stanciu Pop C, Dupont M, Vander Borght T, Rondelet B, Vanderick J, André B, Pirard L, Ocak S. Systemic Inflammation/Nutritional Status Scores Are Prognostic but Not Predictive in Metastatic Non-Small-Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors. Int J Mol Sci. 2023 Feb 10;24(4):3618.

Wauthier L, Favresse J, Hardy M, Douxfils J, Le Gal G, Roy PM, van Es N, Ay C, Ten Cate H, Vander Borght T, Dupont MV, Lecompte T, Lippi G, Mullier F. D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review. Diagnostics (Basel). 2022 Nov 12;12(11):2770.

Longton E, Lawson G, Bihin B, Mathieu I, Hanin FX, Deheneffe S, Vander Borght T, Laloux M, Daisne JF. Individualized Prophylactic Neck Irradiation in Patients with cN0 Head and Neck Cancer Based on Sentinel Lymph Node(s) Identification: Definitive Results of a Prospective Phase 1-2 Study. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):652-661.

Édeline V, Remouchamps V, Isnardi V, Vander Borght T. Multimodality imaging using PET/CT ((18)F)-fluorodeoxyglucose for radiotherapy field delineation of localized Hodgkin lymphoma. Cancer Radiother. 2018 Sep;22(5):384-392.

Berriolo-Riedinger A, Becker S, Casasnovas O, Vander Borght T, Édeline V. Role of FDG PET-CT in the treatment management of Hodgkin lymphoma. Cancer Radiother. 2018 Sep;22(5):393-400.

Karmani L, Levêque P, Bouzin C, Bol A, Dieu M, Walrand S, Vander Borght T, Feron O, Grégoire V, Bonifazi D, Michiels C, Lucas S, Gallez B. Biodistribution of (125)I-labeled anti-endoglin antibody using SPECT/CT imaging: Impact of in vivo deiodination on tumor accumulation in mice. Nucl Med Biol. 2016 Mar 29;43(7):415-423.

Lucas S, Feron O, Gallez B, Masereel B, Michiels C, Vander Borght T. Monte Carlo Calculation of Radioimmunotherapy with (90)Y-, (177)Lu-, (131)I-, (124)I-, and (188)Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts. Comput Math Methods Med. 2015;2015:284360.

Daisne JF, Installé J, Bihin B, Laloux M, Vander Borght T, Mathieu I, Lawson G. SPECT/CT lymphoscintigraphy of sentinel node(s) for superselective prophylactic irradiation of the neck in cN0 head and neck cancer patients: a prospective phase I feasibility study. Radiat Oncol. 2014 May 28;9:121.

Lawson G, Matar N, Nollevaux MC, Jamart J, Krug B, Delos M, Remacle M, Borght TV. Reliability of sentinel node technique in the treatment of N0 supraglottic laryngeal cancer. Laryngoscope. 2010 Nov;120(11):2213-7.

Krug B, Crott R, Roch I, Lonneux M, Beguin C, Baurain JF, Pirson AS, Vander Borght T. Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma. Acta Oncol. 2010;49(2):192-200.